Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.

Liao J, Wang X, Bi Y, Shen B, Shao K, Yang H, Lu Y, Zhang Z, Chen X, Liu H, Wang J, Chu Y, Xue L, Wang X, Liu G.

J Leukoc Biol. 2014 Nov;96(5):675-84. doi: 10.1189/jlb.2HI1113-611RR. Epub 2014 Jun 19.

2.

The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.

Wang X, Bi Y, Xue L, Liao J, Chen X, Lu Y, Zhang Z, Wang J, Liu H, Yang H, Liu G.

Mol Cell Biol. 2015 Feb;35(3):598-609. doi: 10.1128/MCB.01251-14. Epub 2014 Dec 1.

3.

Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells.

Liu G, Bi Y, Wang R, Yang H, Zhang Y, Wang X, Liu H, Lu Y, Zhang Z, Chen W, Chu Y, Yang R.

J Immunol. 2014 Apr 1;192(7):3068-79. doi: 10.4049/jimmunol.1301193. Epub 2014 Feb 24.

4.

Alteration of innate immunity by donor IL-6 deficiency in a presensitized heart transplant model.

Ge F, Yuan S, Su L, Shen Z, He A, Huang T, Gong W.

PLoS One. 2013 Oct 16;8(10):e77559. doi: 10.1371/journal.pone.0077559. eCollection 2013.

5.

Editorial: Dexamethasone and MDSC in transplantation: yes to NO.

Ochando JC, Conde P.

J Leukoc Biol. 2014 Nov;96(5):669-71. doi: 10.1189/jlb.3CE0514-272R. No abstract available.

6.

Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.

Greifenberg V, Ribechini E, Rössner S, Lutz MB.

Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486.

7.

IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, Isse K, Wang Z, Lang M, Stolz DB, Zheng XX, Demetris AJ, Liew FY, Wood KJ, Thomson AW.

J Immunol. 2011 Nov 1;187(9):4598-610. doi: 10.4049/jimmunol.1100519. Epub 2011 Sep 26.

8.

Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Gong W, Ge F, Liu D, Wu Y, Liu F, Kim BS, Huang T, Koulmanda M, Robson SC, Strom TB.

Clin Immunol. 2014 Jul;153(1):8-16. doi: 10.1016/j.clim.2014.03.013. Epub 2014 Mar 30.

PMID:
24691417
9.

SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.

Zhu K, Zhang N, Guo N, Yang J, Wang J, Yang C, Yang C, Zhu L, Xu C, Deng Q, Zhu R, Wang H, Chen X, Shi Y, Li Y, Leng Q.

Int J Biochem Cell Biol. 2014 Sep;54:89-97. doi: 10.1016/j.biocel.2014.07.005. Epub 2014 Jul 15.

PMID:
25035167
10.

Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.

Wu T, Sun C, Chen Z, Zhen Y, Peng J, Qi Z, Yang X, Zhao Y.

J Immunol. 2012 Nov 15;189(10):4989-5000. doi: 10.4049/jimmunol.1200068. Epub 2012 Oct 8.

11.

Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.

Zhang W, Liang S, Wu J, Horuzsko A.

Transplantation. 2008 Oct 27;86(8):1125-34. doi: 10.1097/TP.0b013e318186fccd.

12.

Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells.

Nakamura T, Nakao T, Yoshimura N, Ashihara E.

Am J Transplant. 2015 Sep;15(9):2364-77. doi: 10.1111/ajt.13276. Epub 2015 May 5.

13.

Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.

Schouppe E, Mommer C, Movahedi K, Laoui D, Morias Y, Gysemans C, Luyckx A, De Baetselier P, Van Ginderachter JA.

Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25.

14.

Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity.

Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA.

Blood. 2008 Apr 15;111(8):4233-44. doi: 10.1182/blood-2007-07-099226. Epub 2008 Feb 13.

15.

mTOR limits the recruitment of CD11b+Gr1+Ly6Chigh myeloid-derived suppressor cells in protecting against murine immunological hepatic injury.

Zhang Y, Bi Y, Yang H, Chen X, Liu H, Lu Y, Zhang Z, Liao J, Yang S, Chu Y, Yang R, Liu G.

J Leukoc Biol. 2014 Jun;95(6):961-70. doi: 10.1189/jlb.0913473. Epub 2014 Feb 25.

16.
17.

Dexamethasone inhibits in vivo tumor growth by the alteration of bone marrow CD11b⁺ myeloid cells.

Moon EY, Ryu YK, Lee GH.

Int Immunopharmacol. 2014 Aug;21(2):494-500. doi: 10.1016/j.intimp.2014.06.006. Epub 2014 Jun 19. Erratum in: Int Immunopharmacol. 2014 Oct;22(2):526-7.

PMID:
24953854
18.

Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival.

Choi W, Ji YW, Ham HY, Yeo A, Noh H, Jin SE, Song JS, Kim HC, Kim EK, Lee HK.

J Leukoc Biol. 2016 Dec;100(6):1453-1463. Epub 2016 Jul 1.

PMID:
27370015
19.

mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.

Chen X, Zhang Z, Bi Y, Fu Z, Gong P, Li Y, Yu Q, Jia A, Wang J, Xue L, Yang H, Liu G.

J Leukoc Biol. 2016 Dec;100(6):1349-1362. Epub 2016 Jul 26.

PMID:
27462101
20.

Nitric oxide as a regulatory and effector molecule in the immune system.

Holán V, Krulová M, Zajícová A, Pindjáková J.

Mol Immunol. 2002 May;38(12-13):989-95.

PMID:
12009578

Supplemental Content

Support Center